XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenue $ 810 $ 1,374 $ 2,701 $ 4,004
Cost of revenue 2,525 2,765 7,715 5,131
Gross loss (1,715) (1,391) (5,014) (1,127)
Research and development expenses 23,787 26,123 76,306 77,376
General and administrative expenses 8,474 8,093 24,020 23,642
Selling and marketing expenses 1,520 2,195 5,603 5,415
Total operating expenses 33,781 36,411 105,929 106,433
Operating loss (35,496) (37,802) (110,943) (107,560)
Interest income 2,219 1,164 6,508 2,033
Other income, net 39 135 68 896
Loss before income taxes (33,238) (36,503) (104,367) (104,631)
Income tax provision 0 0 0 0
Net loss (33,238) (36,503) (104,367) (104,631)
Unrealized gain (loss) on available-for-sale securities 915 (752) 2,604 (4,157)
Total comprehensive loss $ (32,323) $ (37,255) $ (101,763) $ (108,788)
Net loss per share, Basic $ (0.15) $ (0.17) $ (0.47) $ (0.48)
Net loss per share, Diluted $ (0.15) $ (0.17) $ (0.47) $ (0.48)
Weighted average shares of common stock outstanding - Basic 222,825,819 217,888,470 221,003,348 216,937,433
Weighted-average shares used in computing net loss per share - diluted 222,825,819 217,888,470 221,003,348 216,937,433